Scopoli's work in the field of mercurialism in light of today's knowledge: Past and present perspectives

American Journal of Industrial Medicine

Volumn 53, Issue 5, 2010, Pages 535-547

  Kobal, Alfred Bogomir ^a   Grum, Darja Kobal ^b  

^a Idrija Mercury Mine ^*  (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Elemental mercury; Melatonin; Mercurialism; Neurotransmitters; Oxidative stress

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; MERCURY; ORGANOMERCURY COMPOUND;

CHEMICALLY INDUCED DISORDER; DEPRESSION; HISTORY; HUMAN; MINING; OCCUPATIONAL DISEASE; REVIEW; SLEEP DISORDER; SLOVENIA;

DEPRESSION; HISTORY, 18TH CENTURY; HUMANS; MERCURY; MINING; NEUROTRANSMITTER AGENTS; OCCUPATIONAL DISEASES; ORGANOMERCURY COMPOUNDS; SLEEP DISORDERS; SLOVENIA;

EID: 77951439818     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20798     Document Type: Review

References (94)

1. Acuna-Castroviejo D, Escames G, Macias M, Munoz-Hoyos A, Molina- Carballo A, Arauzo M, Montes R, Vives F. 1995. Cell protective role of melatonin in the brain. J Pineal Res 19:57-63.
2. Asano S, Eto K, Kurusaki E, Gunji H, Hiraiwa K, Sato M, Sato H, Hasuike M, Hagiwara N, Wakasa H. 2000. Acute inorganic mercury vapor inhalation poisoning. Pathol Int 50:169-174.
3. Aschner M, Syversen T, Souza DO, Rocha JBT, Farina M. 2007. Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res 40:285-291.
4. ATSDR. 1999. Toxicological profile for mercury. Atlanta: US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
5. Boffetta P, Garcia-Gomez M, Pompe-Kirn V, Merler E, Zarizde D, Bellander T, Bulbulyan M, Caballero JD, Ceccarelli F, Colin D, Dizdarevic T, Español S, Kobal A, Petrova N, Sällsten G, Merler E. 1998. Cancer occurrence among European mercury miners. Cancer Causes Control 9:591-599.
6. Burbure C, Buched JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, Smerhovsky Z, Cikrt M, Trzcinka-Ochocka M, Razniewska G, Jakubowsky M, Bernard M. 2006. Renal and neurologic effects of cadmium, lead, mercury and arsenic in children: Evidence of early effects and multiple interactions at the environmental exposure level. Environ Health Perspect 114(4):584-590.
7. Ĉar J. 2006. The Skonca beds of the Idrija ore deposit, 2. Slovenski Geološki Kongres, Book of Abstracts, p 66.
8. Castoldi AF, Cocchini T, Ceccatelli S, Manzo L. 2001. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 55:197-203.
9. Clarkson TW, Magos L. 2006. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609-662.
10. Crawford DR, Davies KJA. 1994. Adaptive response and oxidative stress. Environ Health Perspect 102:25-28.
11. Das SK, Vasudevan DM. 2005. Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases. Ind J Clin Biochem 20:24-28.
12. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371.
13. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette M. 1994. Resetting the biological clock: Mediation of nocturnal circadian shift by glutamate and No. Science 266:1713-1717.
14. Dringen R, Gutterer JM, Herrlinger J. 2000. Glutathione metabolism in brain, metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912-4916.
15. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. 2003. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8:1093-1108.
16. Ebadi M. 1992. Multiple pineal receptors in regulating melatonin synthesis. In: Yu HS, Reiter RJ, editors. Melatonin: Biosynthesis, physiological effects and clinical applications. Boca Raton, FL: CRC Press, p 39-71.
17. Echeveria D, Aposhian HV, Woods JS, Heyer NJ, Aposhian MM, Bittner AC, Mahurin RK, Cianciola M. 1998. Neurobehavioral effects from exposure to dental amalgam: New distinctions between recent exposure and Hg body burden. FASEB J 12:971-980.
18. Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG. 1999. Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 53:1201-1207.
19. Falnoga I, Tušek-Žnidrič M, Horvat M, Stegnar P. 2000. Mercury, selenium and cadmium in human autopsy samples from Idrija residents and mercury mine workers. Environ Res 84:211-218.
20. Fossier P, Blanchard B, Ducrocq C, Leprince C, Tauc L, Baux G. 1999. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation. Neuroscience 93:597-603.
21. Geoffriau M, Brun J, Chazot G, Claustrat B. 1998. The physiology and pharmacology of melatonin in human. Horm Res 49:136-141.
22. Glesinger L. 1950. Opis otrovanja živom kod rudara u Idriji iz 16. stoljeća. Arhiv Hig Rada 1:142-147.
23. Gochfeld M. 2005. Chronologic history of occupational medicine. J Occup Environ Med 47:96-114.
24. Goldwater LJ. 1972. Mercury: A history of quicksilver. Baltimore, MD: York Press.
25. Hribernik I. 1950. Naša opazovanja o profesionalnem zastrupljanju z živim srebrom v Idriji (1946-1950). Arhiv Hig Rada 1:291-299.
26. Huether G, Fettkötter I, Keilhoff G, Wolf G. 1997. Serotonin acts as a radical scavenger and is oxidised to a dimer during the respiratory burst of activated microglia. J Neurochem 69:2096-2101.
27. Hughes RJ, Sack RL, Lewy AJ. 1998. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement. Sleep 21:52-68.
28. Hunter D. 1957. The diseases of occupations. London: English Universities Press Ltd.
29. Hursh JB, Clarkson T, Cherian MG, Vostal J, Mallie V. 1976. Clearance of mercury (Hg-197, Hg-203) vapour inhaled by human subjects. Arch Environ Health 31:302-309.
30. Hursh JB, Sichak SP, Clarkson TW. 1988. In vitro oxidation of mercury by the blood. Pharmacol Toxicol 63:266-273.
31. International Agency for Research on Cancer (IARC). 1997. Silica. Monographs 68. Lyon: IARC.
32. Ikeda M,Komachi H, Sato I, Himi T,Yuasa T, Murota S. 1999. Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum. J Neurosci Res 55:352-356.
33. Jones BE. 1991. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 40:37-56.
34. Joselow MM, Ruiz R, Goldwater LJ. 1968. Absorption and excretion of mercury in man. Arch Environ Health 17:35-38.
35. Kasper S, Neumeister A, Rieder N, Hesselmann B, Ruhrmannn S. 1996. Serotonergic mechanisms in the pathophysiology and treatment of seasonal affective disorder. In: Holick MF, editor. Biologic effects of light. Berlin: W. de Gruyter, p 325-331.
36. Kobal AB. 1975. Beurteilung der Wirksamkeit von persönlichen Schutzausrüstungen an Arbeisplätzen mit hohen Konzentrationen von Quecksilberdämpfen [summary in English]. Zbl Arbeitsmed 12:366-371.
37. Kobal AB. 1990. Varstvo pri delu in zdravstveno varstvo delavcev izpostavljenih slikogenemu prahu in živemu srebru v Rudniku Idrija po letu 1945 [in Slovene] In: Zbornik Radova, VII. Jugoslovenski simpozijum o podzemnoj eksploataciji, Rudarstvo juče, danas, sutra. Bled-Idrija 29.5.-1.6.1990. p 44-52.
38. Kobal AB. 1991. Occupational exposure to elemental mercury and its influence on mercury in blood, erythrocytes, plasma, exhaled breath and urine, and catalase activity in erythrocytes [summary in English]. PhD Thesis, Faculty of medicine, University of Ljubljana, Ljubljana, SI.
39. Kobal AB. 1994. Quecksilber aus Idria-Historisch und aktuell-eine arbeitmedizinische Betrachtung [summary in English]. Zbl Arbeitsmed 44:200-210.
40. Kobal AB, Dizdarevič T. 1997. The health safety programme for workers exposed to elemental mercury at the Idrija Mercury Mine. Water Air Soil Pollut 97:169-184.
41. Kobal AB, Horvat M, Prezelj M, Sesek-Briški A, Krsnik M, Dizdarevič T, Mazej D, Falnoga I, Stibilj V, Arnerič N, Kobal D, Osredkar J. 2004. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol 17:261-274.
42. Kobal AB, Prezelj M, Horvat M, Krsnik M, Gibičar D, Osredkar J. 2008. Glutathione level after long-term occupational elemental mercury exposure. Environ Res 107:115-123.
43. Kobal-Grum D, Kobal AB, Arnerič N, Horvat M,Ženko B, Džeroski S, Osredkar J. 2006. Personality traits in miners with past occupational elemental mercury exposure. Environ Health Perspect 114:290-296.
44. Kopczak A,Korth HG, de Grot H, Kirsch M. 2007. N-nitroso-melatonin release nitric oxide in the presence of serotonin and derivates. J Pineal Res 43:343-350.
45. Kosta L, Byrne AR, ZelenkoV. 1975. Correlation between selenium and mercury in man following exposure to inorganic mercury. Nature 254:238-239.
46. Kunz D, Mahlberg R, Muller C, Tilmann A, Bes F. 2004. Melatonin in patients with reduced REM sleep duration: Two randomized controlled trials. J Clin Endocrinol Metab 89:128-134.
47. Lakari E, Paakko P, Pietarinen-Runtti P, Kinnula VL. 2000. Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. Am J Respir Crit Care Med 161:615-621.
48. Lee YW, Ha MS, Kim YK. 2001. Role of reactive oxygen species and glutathione in inorganic mercury induced injury in human glioma cells. Neurochem Res 26:1187-1211.
49. Leon J, Vives F, Gomez I, Camacho E, Gallo MA, Espinosa A, Escames G, Acuna-Castroviejo D. 1998. Modulation of rat striatal glutamatergic response in search for new neuroprotective agents: Evaluation of melatonin and some kynurenine derivates. Brain Res Bull 45:525-530.
50. Lesky E. 1956. Arbeitsmedizin im 18. Jahrhundert: Werksarzt und Arbeiter im Quecksilberbergwerk Idria [in German]. Wien: Verlag des Notringes der wissenschaftlichen Verbände Österreichs.
51. Liu J, Lei D,Waalkes MP, Beliles RP. 2003. Genomic analysis of the rat lung following elemental mercury vapor exposure. Toxicol Sci 74:174-181.
52. Lucchini R, Calza S, Camerino D, Carta P, Decarli A, Prrinello G, Soleo L, Zefferino R, Alessio L. 2003. Application of a latent variable model for a multicentric study on early effects due to mercury exposure. Neurotoxicology 24:605-616.
53. 2 formation and oxidative stress in vivo and vitro in rat kidney mitochondria. Biochem Pharmacol 45:2017-2024.
54. Magos L, Halbach S, Clarkson TW. 1978. Role of catalase in the oxidation of mercury vapor. Biochem Pharmacol 27:1373-1377. (Pubitemid 8401725)
55. McFarland RB, Reigel H. 1978. Chronic mercury poisoning from a single brief exposure. J Occup Med 20:532-534.
56. McNally L, Bhagwagar Z, Hannestad J. 2008. Inflammation, glutamate, and glia in depression: A literature review. CNS Spectr 13:501-510.
57. Mignot E, Taheri S, Nishino S. 2002. Sleeping with the hypothalamus emerging therapeutic targets for sleep disorders. Nat Neurosci 5:1071-1075.
58. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol Rev 78:189-225.
59. Mlakar I. 1975. Mineraloške, petrografske in kemične kamenine idrijskega rudišča-1. faza. Mezozoik v Sloveniji [in Slovene]. Rudnik živega srebra Idrija, p 331.
60. Murphy K, Delanty N. 2007. Sleep deprivation. A clinical perspective. Sleep Biol Rhythms 5:2-14.
61. Nemery B, Bast A, Behr J, Borm PJA, Bourke SJ, Camus PH, De Vuyst P, Jansen HM, Kinnula VL, Lison D, Pelkonen O, Saltini C. 2001. Interstitial lung disease induced by exogenous agents: Factors governing susceptibility. Eur Respir J 18:30-42.
62. Nielsen-Kudsk F. 1969. Uptake of mercury vapour in blood in vivo and in vitro from Hg-containing air. Acta Pharmacol Toxicol 27:149-160.
63. Pfeifer J. 1989. Zgodovina idrijskega zdravstva [in Slovene]. Mestni muzej Idrija.
64. Piikivi L, Hänninen H. 1989. Subjective symptoms and psychological performance of chlorine-alkali workers. Scand J Work Environ Health 15:69-74.
65. Pintar I. 1954. Johannes Antonius Scopoli in njegovo prizadevanje za obratno higijeno [in Slovene]. Arhiv Hig Rada 5:309-320.
66. Porter DW, Millecchia LL, Willard P, Robinson VA, Ramsey D, McLaurin J, Khan A, Brumbaugh K, Beighley CM, Teaqss A, Castranova V. 2006. Nitric oxide and reactive oxygen species production causes progressive damage in rats after cessation of silica inhalation. Toxicol Sci 90(1):188-197.
67. Queiroz ML, Pena SC, Salles TS, Capitani EM, Saad ST. 1998. Abnormal antioxidant system in erythrocytes of mercury-exposed workers. Hum Exp Toxicol 17:225-230.
68. Rabe-Jablonska J, Szymanska A. 2001. Diurnal profile of melatonin secretion in the acute phase of major depression and remission. Med Sci Monit 7:946-952.
69. Ressler KJ, Nemeroff CB. 2000. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12:2-19.
70. Rodenbeck A, Hajak G. 2001. Neuroendocrine dysregulation in primary insomnia. Rev Neurol 157:57-61.
71. Rosen G. 1943. The history of miners' diseases. New York: Schuman's.
72. Scopoli JA. 1771. De Hydrargyro Idriensi Tentamina Physico- Chymico-Medica, I. De Minera Hydrargyri, II. De Vitriolo Idriensi, III. De Morbis Fossorum Hydrargyri. 2nd edition. Janae et Lepsiae, Joann Guil Hartung.
73. Scopoli JA. 1784. Anfangsgrunde der Metallurgie. Mannheim: Schwan und Götz.
74. Sener G, Sehirli AO, Ayanog-lu-Durler G. 2003. Melatonin protects against mercury (II)-induced oxidative tissue damage in rats. Pharmacol Toxicol 93:290-296.
75. Shafii M, McMilan DR, Key MP, Derrick AM, Kaufman N, Nahimsky ID. 1996. Nocturnal serum melatonin profile in major depression in child and adolescents. Arch Gen Psychiatry 53:1009-1013.
76. Slavec ZZ. 1998. Occupational medicine in Idrija mercury mine in 18th century. Vesalius 2:51-59.
77. Soban D. 2004. Joannes A. Scopoli-Carl Lineaus (Dopisovanje/ Correspondence 1760-1775). Ljubljana: Prirodoslovno društvo Slovenije, Slovenan, Natural History Society.
78. Soban D, Ruprecht J, Keys TE, Schneck HJ. 1989. The history of scopolamine-With special reference to its use in anesthesia. Anaesthesiol Reanim 14:43-54.
79. Soleo L, Urbano ML, Petrera V, Ambrosi L. 1990. Effects of low exposure to inorganic mercury on psychological performance. Br J Ind Med 47:105-109.
80. Solis MT, Yuen E, Cortez PS, Goebel PJ. 2000. Family poisoned by mercury vapor inhalation. Am J Emerg Med 18:599-602.
81. Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi- Perumal SR, Parry B, Cardinali DP. 2006. Melatonin in mood disorders. Word J Biol Psychiatry 7:138-151.
82. Starc V. 1998. Circadian rhythms and readiness to work II. Impact of sleep on circadian rhythms [abstract in English]. Zdrav Vestn 67:733-743.
83. Stone BM, Tumer C, Mils SL, Nicholson AN. 2000. Hypnotic activity of melatonin. Sleep 23:663-669.
84. Tan DX, Manchester LC, Reiter RJ, Qi W-B, Karbovnik M, Calvo JR. 2000. Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept 9:137-159.
85. Tollefson GD. 1989. Serotonin and alcohol: interrelationship. Psychopathology 22:37-48.
86. TurekFW, Gillette MU. 2004. Melatonin, sleep, and circardian rhythms: Rationale for development of specific melatonin agonist. Sleep Med 5:523-532.
87. Valvasor JW. 1689. Die Ehre des Herzogtums Crain, Laybach.
88. van Heeringen K. 2001. Suicide, serotonin and the brain. Crisis 22: 66-70.
89. Vazques J, Baghdoyan HA. 2001. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. AJP-Regul Integr Comp Physiol 280:598-601.
90. Verbič M. 1993. Naselbina do konca 16. stoletja/The settlement up to the end of the 16th century (abstract in English). Idrijska Obzorja/Idrija Horizons, Pet Stoletji rudnika in mesta/Five Centuries of the Mine and the Town, p 29-43.
91. Wenk GL. 1997. Central cholinergic system and cognition. Annu Rev Psychol 48:649-684.
92. WHO. 1976. Environmental health criteria I, mercury. Geneva: World Health Organization.
93. WHO. 1991. Environmental health criteria 118, inorganic mercury. Geneva: World Health Organization.
94. Yoshida M, Satoh M, Shimada A, Yasutake A, Sumi Y, Tohyama C. 1999. Pulmonary toxicity caused by acute exposure to mercury vapor is enhanced in metallothionein-null mice. Life Sci 64(20):1861-1867.